METTL3 and non-small cell lung carcinoma: RIP assay coupled with PCR confirmed the m6A modification of GLI1/SOX2OT and the direct interaction between GLI1/SOX2OT and METTL3/14 or IGF2BP2 in NSCLC cells (Fig. 4B).